Myotoxicity

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ATROPOS: Survival Analysis of ICI-associated Myocarditis	Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Myotoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiomyopathy, cardiovascular disorder, heart disorder, injury, muscle tissue disorder, musculoskeletal system disorder, myocarditis, nervous system disorder, neuromuscular disease, radiation injury	Recruiting	Not stated	2026-06-10		NCT07633587
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)	Arrhythmias, Cardiac, Chemically-Induced Disorders, Chronic Pain, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Muscle Hypotonia, Myotoxicity, Neurologic Manifestations, Neuromuscular Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Succinylcholine Sensitivity, Urogenital Diseases, acute kidney injury, butyrylcholinesterase deficiency, cardiovascular disorder, heart disorder, injury, kidney disorder, kidney failure, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, radiation injury, urinary system disorder	Recruiting	Not applicable	2024-11-27		NCT06707532

Clinical trials